Find your next paid study

Multiple MyelomaSecondary Immunodeficiency

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT06682988

Phase 3

A Multicenter, Randomized, Controlled, Open-label, Group-Sequential, Phase 3 Study to Investigate the Efficacy, Safety, and Tolerability of Intravenous Gammagard Liquid (Immune Globulin Infusion, 10%) for Primary Infection Prophylaxis Compared With Secondary Infection Prophylaxis in Adult Subjects With Multiple Myeloma Receiving B-Cell Maturation AntigenxCD3-Directed Bispecific Antibody Therapy

Multiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 …

~$50 – $2,250

Actual pay is set by the research site.

TakedaNCT06980480

Nicotine Use DisorderSmoking CessationSmoking Cessation Intervention

Enhancing the Implementation of Tobacco Treatment: A Community-responsive Approach

The goal of this study is to: partner with Respiratory Health Association and determine barriers and unmet smoking cessation treatment needs from leaders in be…

University of ChicagoNCT06837220

Actual pay is set by the research site.

COPD (Chronic Obstructive Pulmonary Disease)

Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD

1\) Purpose: To improve pulmonary rehabilitation outcomes for individuals with COPD by evaluating the effectiveness of a hip-assisted exoskeleton during a sing…

University of NebraskaNCT07703527

Actual pay is set by the research site.

Mild Cognitive ImpairmentDementiaBPSD+2 more

Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD

The purpose of this study is to test the usefulness and the effect of Smart Virtual Reminiscence (SVR) therapy intervention on the Behavioral and Psychological…

Indiana UniversityNCT07499570

Actual pay is set by the research site.

Phase 2

Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial

Chronic pain symptoms are very common among U.S. Military Veterans and have a profound negative impact on mental health symptoms and quality of life, in additi…

Chronic Low Back Pain

VA Office of Research and DevelopmentNCT05935761

~$75 – $1,800

Actual pay is set by the research site.

Thermogenic Responses to Fasting and Overfeeding in Women: a Potential Mechanism Contributing to Postmenopausal Weight Gain

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The…

Obesity

University of Colorado, DenverNCT06610162

Actual pay is set by the research site.

Phase 1

The Impact of Phosphate Metabolism on Healthy Aging

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial…

HypophosphatemiaRicketsHypercalciuria+2 more

Yale UniversityNCT03771105

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

[C-11]NPA PET-amphetamine in Cocaine Use Disorders (Aim 2)

This study uses \[11C\]NPA positron emission tomography (PET) and a d-amphetamine challenge to image amphetamine induced dopamine release in the striatum in su…

Cocaine Use Disorder

Rajesh NarendranNCT05011760

~$150 – $4,500

Actual pay is set by the research site.

Phase 1

A Phase 1, Open-label, Dose Escalation and Dose Expansion, Multicenter Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML)

This is a clinical study aiming to assess pharmacokinetics, pharmacodynamics and preliminary efficacy of ZE46-0134 in patients with FLT3 and spliceosome mutate…

AML With Gene Mutations

Lomond Therapeutics Holdings, Inc.NCT06366789

~$150 – $4,200

Actual pay is set by the research site.

Phase 2

A Phase 2 Study of Microsatellite Stable Colorectal Cancer (Stage 2 or 3) With Radiographic Occult Molecular Residual Disease Treated With Botensilimab (AGEN1181; Bot) Plus Balstilimab (AGEN2034, Bal) After Established Definitive Therapy (COMBAT Study)

This phase II trial tests the effect of the botensilimab in combination with balstilimab in treating patients with stage II/III colorectal adenocarcinoma with …

Colorectal AdenocarcinomaStage II Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8

National Cancer Institute (NCI)NCT07551596

~$75 – $1,800

Actual pay is set by the research site.

Molecular Fingerprinting of Lung Cancer

RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and ide…

Lung Cancer